US Patent 12091413 Inhibitors of NEK7 kinase
Patent 12091413 was granted and assigned to Halia Therapeutics, Inc. on September, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12091413 Inhibitors of NEK7 kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
